Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel versus clopidogrel + aspirin after lower extremity peripheral transluminal angioplasty
2021-006611-29Phase 4Active
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in arteriosclerosis obliterans comparing Clopidogrel monotherapy with Clopidogrel + aspirin (2 arms). Primary endpoint: Cardiovascular adverse events at 1 year. Started Jun 2022; status: active.
02
Drugs
clopidogrelaspirin
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on 2021-006611-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006611-29.